4/A//SEC Filing
Aiello Joshua 4/A
Accession 0001213900-23-041615
CIK 0001814114other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:40 PM ET
Size
6.6 KB
Accession
0001213900-23-041615
Insider Transaction Report
Form 4/AAmended
Aiello Joshua
Principal Accounting Officer
Transactions
- Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+18,228→ 18,228 totalExercise: $10.00Exp: 2032-08-17→ Common Stock (18,228 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently misstated the expiration date of one class of nonstatutory stock options ("NSOs"). In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to correct the incorrect expiration date in Table II, Column 6 to August 17, 2032; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
- [F2]The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.
- [F3]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 39,200 shares of Legacy Orchestra Common Stock for $4.65 per share.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001960418
Filing Metadata
- Form type
- 4/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:40 PM ET
- Size
- 6.6 KB